Unilabs SA and Natera Initiate Partnership for Distribution of Non-Invasive Prenatal Test, Panorama™, in Switzerland/Scandinavia

Published: Jun 13, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

GENEVA & SAN CARLOS, Calif.--(BUSINESS WIRE)--Unilabs, a leading diagnostics company in Europe, and Natera, a leading innovator in prenatal genetic testing, announced today that Unilabs will distribute Natera’s non-invasive prenatal screening test, Panorama™, across its wide network in Switzerland and Scandinavia. Panorama was launched in March 2013 for the detection of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome) and select sex chromosome abnormalities, such as monosomy X (Turner’s syndrome). “Panorama™ marks a significant advance in the field of prenatal testing as it has shown remarkable sensitivity and specificity across multiple aneuploidies,” said Thomas Brinkmann, M.D., group chief medical officer of Unilabs. “By providing physicians and expectant mothers with accurate information in a non-invasive test, Panorama contributes to our goal of ensuring that expectant mothers receive accurate information to guide their doctor’s clinical decisions.”

Help employers find you! Check out all the jobs and post your resume.

Back to news